Roy Doumani

CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN

GeneFluidics, Inc. develops and distributes technology to find and identify DNA and RNA, proteins and small molecules without the use of amplification methods. The company serves the markets which include clinical diagnostics, animal testing, environmental monitoring and biothreat detection. The company was founded by Vincent J. Gau in 2000 and is headquartered in Monterey Park, CA.

Founded in 1977, Fulcrum Capital Group LLC is a private equity firm located in Los Angeles. The firm manages separate private equity capital pools including Fulcrum Venture Capital Corp., Fulcrum Capital Management LLC and Fulcrum Capital Partners LP

Sofie Biosciences, Inc. operates as a diagnostics company that provides molecular imaging probes and devices to help scientists and physicians investigate the biology of disease. It combines the discovery and development of new PET imaging probes with innovative imaging systems and chemistry platforms to provide researchers and physicians with tools to better understand the biology of disease. The company was founded by Owen N. Witte, Michael E. Phelps, Jim Heath, Johannes Czernin, and Caius Radu in 2008 and is headquartered in Culver City, CA.

First Interstate Bank is the investment management subsidiary of First Interstate BancSystem, Inc. (NASDAQ: FIBK), a financial holding company headquartered in Billings, Montana. Founded in 1971, the firm provides wealth management services to individuals and businesses.

Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA.

Xiamen International Bank Co., Ltd. engages in the provision of commercial banking services. Its business scopes include personal and corporate deposits, loans, bonds, settlements, interbank borrowing, foreign exchanges, insurance, and credit services. The company was founded on August 31, 1985 and is headquartered in Shenzhen, China.